From the Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, Ohio and the Ohio State University Fisher College of Business, Columbus, Ohio.
South Med J. 2021 Feb;114(2):73-76. doi: 10.14423/SMJ.0000000000001204.
To evaluate the willingness of young adult males to use male hormonal contraception and to determine the most desirable formulation.
An institutional review board-approved survey measuring the willingness to use MHC was dispersed to two distinct populations: University of Cincinnati postgraduate programs and Cincinnati Health Department clinics. Questions on the survey allowed for the collection of demographic characteristics, as well as the preferred method of MHC, and concerns regarding potential adverse effects. This survey was directed at young adult males; therefore, only male participants who were 18 to 35 years old were included for analysis. Results were reported as frequencies in each group and χ analyses were performed to compare groups, with a < 0.05 considered significant.
Of 162 total survey participants, 45% would use MHC, whereas 30.9% were unsure and 23.5% would not use MHC. Overall, the University of Cincinnati survey population was more likely to be interested in using MHC than the Cincinnati Health Department population ( < 0.05). In both populations, most were interested in using the injectable form. Cited concerns deterring participants from using MHC were different between these two populations, with University of Cincinnati participants more frequently expressing concerns about possible failure of the contraceptive method, whereas Cincinnati Health Department participants had concerns about potential adverse effects ( < 0.001).
There is significant interest among young adult males in using various forms of MHC, especially in injectable form. Differences in views of MHC were seen in two distinct male populations. Specifically, males who achieved a higher level of education, were employed, or in a relationship were found to more frequently be willing to use MHC. With further research and funding, MHC may serve as a significant way to decrease unintended pregnancies in the future.
评估年轻成年男性使用男性激素避孕的意愿,并确定最理想的制剂。
一项机构审查委员会批准的调查评估了使用 MHC 的意愿,并将其分发给两个不同的人群:辛辛那提大学研究生项目和辛辛那提卫生部诊所。调查中的问题允许收集人口统计学特征,以及对 MHC 的首选方法和对潜在不良反应的担忧。这项调查针对的是年轻成年男性,因此,只有年龄在 18 至 35 岁之间的男性参与者才被纳入分析。结果以每组的频率报告,并进行 χ 分析比较组间差异,以 < 0.05 为显著差异。
在 162 名总调查参与者中,45%的人愿意使用 MHC,30.9%的人不确定,23.5%的人不愿意使用 MHC。总的来说,辛辛那提大学的调查人群比辛辛那提卫生部的人群更有可能对使用 MHC 感兴趣(< 0.05)。在这两个人群中,大多数人都有兴趣使用注射形式。这两个群体中,阻止参与者使用 MHC 的原因不同,辛辛那提大学的参与者更频繁地表达了对避孕方法可能失败的担忧,而辛辛那提卫生部的参与者则对潜在的不良反应表示担忧(< 0.001)。
年轻成年男性对使用各种形式的 MHC 有很大的兴趣,尤其是注射形式。在两个不同的男性人群中,对 MHC 的看法存在差异。具体来说,受教育程度较高、有工作或有伴侣的男性更愿意使用 MHC。随着进一步的研究和资金投入,MHC 可能成为未来减少意外怀孕的重要手段。